Sun Pharma to acquire Organon for Inorganic Growth - The Financial World
Sun Pharma→Organon
May 1, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Tenet Healthcare has acquired United Surgical Partners International, a ambulatory surgery business in Texas, for $125 million. United Surgical Partners International operates ambulatory surgery centers in the Dallas area, supporting outpatient procedures and expanding local surgical capacity. Tenet Healthcare acquisitions in ambulatory surgery acquisition aim to grow its ASC footprint and strengthen its healthcare M&A pipeline in TX. The United Surgical Partners International acquisition is an add on acquisition by a strategic buyer, with Tenet deploying $125 million across seven ASC deals in Q1 2026 and targeting additional healthcare deals TX.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharma→Organon
May 1, 2026
Vireo Growth→Fluent
May 1, 2026
United Surgical Partners International→ASCs (seven acquired)
Apr 30, 2026
Volaris Group→Interplayers
Apr 30, 2026
Vitalist→Somatix
Apr 30, 2026